| 2018 update of the EULAR recommendations for the management of Behçet’s syndrome G Hatemi, R Christensen, D Bang, B Bodaghi, AF Celik, F Fortune, ... Annals of the rheumatic diseases 77 (6), 808-818, 2018 | 784 | 2018 |
| Management of major organ involvement of Behçet’s syndrome: a systematic review for update of the EULAR recommendations Y Ozguler, P Leccese, R Christensen, SN Esatoglu, D Bang, B Bodaghi, ... Rheumatology 57 (12), 2200-2212, 2018 | 112 | 2018 |
| Pulmonary artery involvement in Behçet׳ s syndrome: Effects of anti-Tnf treatment V Hamuryudan, E Seyahi, S Ugurlu, M Melikoglu, G Hatemi, Y Ozguler, ... Seminars in arthritis and rheumatism 45 (3), 369-373, 2015 | 81 | 2015 |
| Management of skin, mucosa and joint involvement of Behçet’s syndrome: a systematic review for update of the EULAR recommendations for the management of Behçet’s syndrome P Leccese, Y Ozguler, R Christensen, SN Esatoglu, D Bang, B Bodaghi, ... Seminars in Arthritis and Rheumatism 48 (4), 752-762, 2019 | 78 | 2019 |
| Characteristics predicting tuberculosis risk under tumor necrosis factor-α inhibitors: report from a large multicenter cohort with high background prevalence B Kisacik, ON Pamuk, AM Onat, SB Erer, G Hatemi, Y Ozguler, Y Pehlivan, ... The Journal of rheumatology 43 (3), 524-529, 2016 | 64 | 2016 |
| Factors affecting the tuberculosis risk in patients receiving anti-tumor necrosis factor-α treatment S Borekci, E Atahan, D Demir Yilmaz, N Mazıcan, B Duman, Y Ozguler, ... Respiration 90 (3), 191-198, 2015 | 48 | 2015 |
| Myelopathy in Behçet's disease: the Bagel sign U Uygunoglu, B Zeydan, Y Ozguler, S Ugurlu, E Seyahi, N Kocer, C Islak, ... Annals of neurology 82 (2), 288-298, 2017 | 44 | 2017 |
| Clinical course of acute deep vein thrombosis of the legs in Behçet’s syndrome Y Ozguler, G Hatemi, F Cetinkaya, K Tascilar, V Hamuryudan, S Ugurlu, ... Rheumatology 59 (4), 799-806, 2020 | 40 | 2020 |
| Developing a core set of outcome measures for Behçet disease: report from OMERACT 2016 G Hatemi, A Meara, Y Ozguler, H Direskeneli, A Mahr, E Easley, ... The Journal of rheumatology 44 (11), 1750-1753, 2017 | 31 | 2017 |
| Management of Behçet's syndrome Y Ozguler, G Hatemi Current opinion in rheumatology 28 (1), 45-50, 2016 | 31 | 2016 |
| Core set of domains for outcome measures in Behçet's syndrome G Hatemi, A Meara, Y Özgüler, H Direskeneli, A Mahr, B Shea, E Cam, ... Arthritis care & research 74 (4), 691-699, 2022 | 27 | 2022 |
| Current status, goals, and research agenda for outcome measures development in Behçet syndrome: report from OMERACT 2014 G Hatemi, Y Ozguler, H Direskeneli, A Mahr, A Gul, V Levi, SZ Aydin, ... The Journal of rheumatology 42 (12), 2436-2441, 2015 | 26 | 2015 |
| Management of Behçet's syndrome Y Ozguler, G Hatemi, H Yazici Current opinion in rheumatology 26 (3), 285-291, 2014 | 25 | 2014 |
| Re-initiation of biologics after the development of tuberculosis under anti-TNF therapy Y Ozguler, G Hatemi, S Ugurlu, E Seyahi, M Melikoglu, S Borekci, ... Rheumatology international 36, 1719-1725, 2016 | 23 | 2016 |
| Faecal but not serum calprotectin levels look promising in predicting active disease in Behçet’s syndrome patients with gastrointestinal involvement SN Esatoglu, I Hatemi, Y Ozguler, G Hatemi, H Uzun, AF Celik, H Yazici Clin Exp Rheumatol 36 (6 Suppl 115), 90-6, 2018 | 22 | 2018 |
| Exacerbation of Behcet’s syndrome and familial Mediterranean fever with menstruation G Guzelant, Y Ozguler, SN Esatoglu, G Karatemiz, H Ozdogan, ... Clin Exp Rheumatol 35 (Suppl 108), 95-99, 2017 | 21 | 2017 |
| Patients’ experiences with Behçet’s syndrome: structured interviews among patients with different types of organ involvement Y Ozguler, PA Merkel, M Gurcan, C Bocage, W Eriksen, Z Kutlubay, ... Clinical and experimental rheumatology 37 (Suppl 121), 28, 2019 | 19 | 2019 |
| Meeting Report Highlights of the 17th International Conference on Behçet’s syndrome SN Esatoglu, G Hatemi, P Leccese, I Olivieri Clin Exp Rheumatol 34 (102), S3-S9, 2016 | 14* | 2016 |
| The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet’s syndrome G Ozcifci, T Aydin, Z Atli, II Balkan, F Tabak, M Oztas, Y Ozguler, S Ugurlu, ... Rheumatology international 42 (1), 101-113, 2022 | 13 | 2022 |
| Biosimilar infliximab for Behçet’s syndrome: a case series E Dincses, SN Esatoglu, Y Ozguler, U Uygunoglu, V Hamuryudan, ... Clin Exp Rheumatol 37 (Suppl 121), 111-115, 2019 | 13 | 2019 |
